Stanford University, School of Medicine
Palo Alto, California, 94304, United States
NCT Number: NCT03174925
This clinical trial studies how well ultrasound elastography works in assessing the cancer status of potentially malignant thyroid nodules.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Palo Alto, California, 94304, United States
PRIMARY OBJECTIVES:
Determine the utility of ultrasound elastography in evaluation of thyroid nodules being evaluated for the presence of cancer.
Elastography measures the passages of ultrasound shear waves through tissue to gauge the stiffness and compressibility of the tissue, collectively "tissue stiffness," and may be a better way to image thyroid nodules. Tissue stiffness is a physiological parameter that is being evaluated for differences between non-cancerous (benign) and cancerous thyroid nodules.
Participants will undergo elastography over the 10 minutes prior to either fine needle aspiration of a biopsy specimen or surgical resection of the thyroid nodule. Tissue specimens from the biopsy specimen or surgical resection will be assessed pathologically to determine actual cancer status.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Shear Wave Elastography
Time frame: 1 week
Potentially cancerous thyroid nodules will be assessed elastographically, and cancer status will be determined from a fine needle aspiration biopsy results or the surgically excised nodule. The outcome will be reported as median tissue stiffness with standard deviation for nodules that were determined non-cancerous (benign), cancerous, or indeterminate.
Stanford University
Other
Elastography in Thyroid Nodule Evaluation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04759911
Adenocarcinoma, Adenocarcinoma, Papillary
Baltimore, Maryland, United States
View Trial DetailsNCT04742608
Endocrine Gland Neoplasms, Endocrine System Diseases
Los Angeles, California, United States
View Trial DetailsNCT04463719
Endocrine Gland Neoplasms, Endocrine System Diseases
Gainesville, Florida, United States
View Trial DetailsNCT05583097
Endocrine Gland Neoplasms, Endocrine System Diseases
Gothenburg, Sweden
View Trial Details